GBMA Education, the educational arm of the Generics and Biosimilar Medicines Association, was awarded the Biosimilar Education Grant by the Australian Government in April 2018. Over a 3-year period, the initiative will deliver a biosimilar education program to Australian healthcare professionals and consumers.
This session will give an overview of the key focus areas in the market and provide an update on grant activities planned for the 2018-19 year.
Speaker: David Ford, Executive Director Pharmacy and Redevelopment, North East Health Wangaratta
When: 4.00pm – 4.45pm, Friday 7 September